United Therapeutics reported $5.82 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 5.82 6.94 6.63 May/06
FY2025Q4 Dec/2025 7.70 7.07 6.19 Feb/25
FY2025Q3 Sep/2025 7.16 7.43 6.39 Oct/29
FY2025Q2 Jun/2025 6.41 7.35 5.85 Jul/30
FY2025Q1 Mar/2025 6.63 6.53 6.17 Apr/30




Eps Change Date
Amarin USD 0.14 0.06 Dec/2025
Ardelyx USD -0.15 0.15 Mar/2026
Baxter International USD 0.36 0.08 Mar/2026
Bayer EUR 2.71 2.09 Mar/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
Insmed USD -0.76 0.78 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
Moderna USD -3.4 1.29 Mar/2026
Omeros USD -1.12 0.37 Jun/2024
Pfizer USD 0.75 0.09 Mar/2026
PTC Therapeutics USD -0.03 1.64 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Teva Pharmaceutical Industries USD 1.57 1.41 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026